生命科学资讯

In Structure licensing deal, Roche commits $100M to shore up GLP-1 position

Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs

Bright Minds shines with phase 2 win for anti-seizure serotonin receptor activator

Boehringer continues kidney disease dealmaking run with $120M Variant Bio pact

Amgen to acquire Dark Blue Therapeutics for up to $840M

Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treat - PharmiWeb.com

From Young Researcher Award Finalist to International Collaborator: Two Visits to Promega

In Structure licensing deal, Roche commits $100M to shore up GLP-1 position - Fierce Biotech

Illumina launches cloud-based platform for multiomic data analysis - Investing.com

Roche's patent deal with Structure; AstraZeneca reports lupus data

Protagonist 'strongly leaning' toward opting out of Takeda profit-sharing deal

Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference - BioSpace

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis - Illumina

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis - Illumina

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis - PR Newswire

Bottleneck size drives the evolution of cooperative traits in an aggregative multicellular myxobacterium

A light-entrained clock mechanism in a hydrozoan jellyfish synchronizes evening gamete release

Here's How Much You'd Have If You Invested $1000 in Thermo Fisher Scientific a Decade Ago - Nasdaq

CDC, following Trump’s orders, weakens US stance on childhood vaccinations

Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement - BioSpace